Ironwood Pharmaceuticals, Inc. (IRWD)
3.525
+0.02
(+0.71%)
USD |
NASDAQ |
Oct 19, 14:45
Ironwood Pharmaceuticals Cash from Operations (Annual) : 127.04M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 127.04M |
| December 31, 2024 | 103.55M |
| December 31, 2023 | 183.43M |
| December 31, 2022 | 273.76M |
| December 31, 2021 | 261.90M |
| December 31, 2020 | 168.84M |
| December 31, 2019 | 10.72M |
| December 31, 2018 | -70.88M |
| December 31, 2017 | -99.56M |
| December 31, 2016 | -25.68M |
| Date | Value |
|---|---|
| December 31, 2015 | -106.33M |
| December 31, 2014 | -155.57M |
| December 31, 2013 | -272.86M |
| December 31, 2012 | -69.63M |
| December 31, 2011 | -75.24M |
| December 31, 2010 | -67.90M |
| December 31, 2009 | -3.998M |
| December 31, 2008 | -28.20M |
| December 31, 2007 | -6.759M |
| December 31, 2006 | -33.53M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AbbVie, Inc. | 19.03B |
| Xencor, Inc. | -135.12M |
| Viking Therapeutics, Inc. | -278.68M |
| IDEAYA Biosciences, Inc. | -71.10M |
| BioMarin Pharmaceutical, Inc. | 827.99M |